Microsofts AI Cost Dilemma When Automation Bills Exceed Human Payroll White House and China Announce Trade Deals on Soybeans and Rare Earths Following TrumpXi Summit Southeast Asias Biofuel Push Strains Food Supplies and Export Capacity Powell Vows No Shadow Chair Role but Historic Fed Meeting with Former Chair Looms HDFC Banks Fundamentals Underpin LongTerm Prospects Amid Stock Weakness SP 500 and Nasdaq Hit Record Closings on AI Optimism Micron Reaches 1 Trillion Milestone FTFT Q2 2024 Earnings Net Loss of 009 Per Share as Company Pivots White Mountains Insurance Group WTM Q2 2025 Earnings EPS Misses Estimates but Stock Edges Higher nVent Electric Q1 2026 Earnings Solid EPS Beat Despite Tepid Market Reaction IDR Q1 2026 Earnings EPS Misses Estimates as Stock Slips 29 GAIA Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress Waste Connections WCN Holds Steady Near Resistance as Volume Remains Subdued Oyster Enterprises II Acquisition Corp Units OYSEU Holds Steady at 1031 as SPAC Units Trade in Narrow Range Westport Fuel Systems WPRT Hovers Near Support After Modest Decline InflaRx NV IFRX Nears Key Support After 25 Decline Technical and Sector Context VisionWave Holdings Warrants VWAVW Edge Higher as Stock Tests Key Resistance Ferrari Luce EV Faces Market Scrutiny After Social Media Backlash INVH Q1 2026 Earnings Strong EPS Beat Fails to Boost Sentiment as Stock Edges Lower HysterYale Inc HY Slips on Mild Session Holds Above Key Support Nutrien NTR Q1 2026 Earnings EPS Miss Amidst Fertilizer Market Pressures Independent Bank Corporation IBCP Q1 2026 Earnings Modest EPS Beat Amid Tepid Market Response Goldcom Inc GOLD Q1 2026 Earnings Massive EPS Beat Drives Shares Higher ULTA Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains on Resilient Demand CAVA Q1 2026 Earnings EPS Beat but Stock Slips on Mixed Sentiment TTWO Q1 2026 Earnings Earnings Beat Fails to Lift Shares as Market Digests Outlook CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics